Virtual Testis Cancer Lay Support and Survivorship Aim 2

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Nov 20, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how virtual support can help men with testicular cancer feel better and improve their overall quality of life. Participants from North Carolina will be divided into two groups: one group will use a special online support platform, while the other group will only receive educational materials about their condition. The study will compare how both groups are doing emotionally, their confidence in managing their health, the financial impact of their treatment, and their quality of life after three and six months.

To join the trial, men must be between 18 and 95 years old and have been diagnosed with germ cell testicular cancer within the last five years. They also need to be comfortable with the study procedures and able to give their consent to participate. Unfortunately, women and non-English speakers cannot take part, and those currently receiving treatment for another cancer or actively undergoing chemotherapy, radiation, or surgery for testicular cancer will also be excluded. This study aims to find out whether the virtual support makes a difference in how these men cope with their diagnosis and treatment.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Men within 5 years of their initial diagnosis of germ cell testicular cancer.
• • The subject is willing and able to comply with study procedures based on the judgment of the investigator.
• • Adults aged 18-95 years old.
• • Electronic informed consent was obtained to participate in the study.
• Exclusion Criteria:
• • Woman gender
• • Non-English speaking
• • Unwilling or unable to complete informed consent.
• • On active treatment for another cancer.
• • Actively receiving chemotherapy, radiation, or surgery for testicular cancer.